CA2351794A1 - Endoluminal prosthesis for treatment of tissue separation condition - Google Patents

Endoluminal prosthesis for treatment of tissue separation condition Download PDF

Info

Publication number
CA2351794A1
CA2351794A1 CA002351794A CA2351794A CA2351794A1 CA 2351794 A1 CA2351794 A1 CA 2351794A1 CA 002351794 A CA002351794 A CA 002351794A CA 2351794 A CA2351794 A CA 2351794A CA 2351794 A1 CA2351794 A1 CA 2351794A1
Authority
CA
Canada
Prior art keywords
stent graft
coiled
turns
radially expanded
condition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002351794A
Other languages
French (fr)
Inventor
Katherine J. Klumb
Thomas J. Fogarty
Kirti P. Kamdar
Bradley B. Hill
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vascular Architects Inc
Original Assignee
Vascular Architects Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vascular Architects Inc filed Critical Vascular Architects Inc
Publication of CA2351794A1 publication Critical patent/CA2351794A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/88Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure the wire-like elements formed as helical or spiral coils
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/95Instruments specially adapted for placement or removal of stents or stent-grafts
    • A61F2002/9505Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument
    • A61F2002/9511Instruments specially adapted for placement or removal of stents or stent-grafts having retaining means other than an outer sleeve, e.g. male-female connector between stent and instrument the retaining means being filaments or wires

Abstract

An endoluminal prosthesis includes a coiled body and a graft material covering at least part of the coiled body to create a coiled stent graft. The average stent graft diameter to turns width ratio may be about 0.8 to 1 to about 2.4 to 1 when expanded.

Description

ENDOLUMINAL PROSTHESIS FOR TREATMENT OF
TISSUE SEPARATION CONDITION
BACKGROUND OF THE INVENTION
The present invention provides devices and methods for the endoluminal placement of prostheses, particularly within the vascular system for the treatment of cardiovascular disease, such as vascular stenoses, dissections and other tissue separation conditions, aneurysms, and the like. The apparatus and methods, however, are also useful for placement in other body lumens, such as the ureter, urethra, biliary tract, gastrointestinal tract and the like, for the treatment of other conditions which may benefit from the introduction of a reinforcing or protective structure within the body lumen. The prostheses will be placed endoluminally. As used herein, "endoluminally" will mean placement by percutaneous or cutdown procedures, wherein the prosthesis is transluminally advanced through the body lumen from a remote location to a target site in the lumen. In vascular procedures, the prostheses will typically be introduced "endovascularly" using a catheter over a guidewire under fluoroscopic guidance. The catheters and guidewires may be introduced through conventional access sites to the vascular system, such as through the femoral artery, or brachial and subclavian arteries, for access to the target site.
An endoluminal prosthesis typically comprises at least one radially expansible, usually cylindrical, body segment. By "radially expansible," it is meant that the body segment can be converted from a small diameter configuration (used for endoluminal placement) to a radially expanded, usually cylindrical, configuration which is achieved when the prosthesis is implanted at the desired target site. The prosthesis may be non-resilient, e.g., malleable, thus requiring the application of an internal force to expand it at the target site. Typically, the expansive force can be provided by a balloon catheter, such as an angioplasty balloon for vascular procedures.
Alternatively, the prosthesis can be self expanding. Such self expanding structures may be provided by a temperature-sensitive superelastic material, such as Nitinol, which naturally assumes a radially expanded condition once an appropriate temperature has been reached.
The appropriate temperature can be, for example, a temperature slightly below normal body
2 temperature; if the appropriate temperature is above normal body temperature, some method of heating the structure must be used. Another type of self expanding structure uses resilient material, such as a stainless steel or superelastic alloy, and forming the body segment so that it possesses its desired, radially-expanded diameter when it is unconstrained, e.g., released from radially constraining forces of a sheath.
To remain anchored in the body lumen, the prosthesis will remain partially constrained by the lumen. The self expanding prosthesis can be delivered in its radially constrained configuration, e.g. by placing the prosthesis within a delivery sheath or tube and retracting the sheath at the target site. Such general aspects of construction and delivery modalities are well-known in the art.
The dimensions of a typical endoluminal prosthesis will depend on its intended use. Typically, the prosthesis will have a length in the range from 0.5 cm to 10 cm, usually being from about 0.8 cm to 5 cm, for vascular applications. The small (radially collapsed) diameter of cylindrical prostheses will usually be in the range from about 1 mm to 10 mm, more usually being in the range from 1.5 mm to 6 mm for vascular applications. The expanded diameter will usually be in the range from about 2 mm to 50 mm, preferably being in the range from about 25 mm to 45 mm for aortic applications.
One type of endoluminal prosthesis includes both a stmt component and a graft component. These endoluminal prostheses are often called stmt grafts. A
stmt graft is typically introduced using a catheter with both the stmt and graft in contracted, reduced-diameter states. Once at the target site, the stmt and graft are expanded. After expansion, the catheter is withdrawn from the vessel leaving the stmt graft at the target site. Grafts may be made of, for example, PTFE, ePTFE or Dacron polyester.
Grafts are used within the body for various reasons, such as to repair damaged or diseased portions of blood vessels such as may be caused by injury, disease, or an aneurysm. It has been found effective to introduce pores into the walls of the graft to provide ingrowth of tissue onto the walls of the graft. With larger diameter grafts, woven graft material is often used. In small and large diameter vessels, porous fluoropolymers, such as ePTFE, have been found useful.
Coil-type stems can be wound about the catheter shaft in torqued compression for deployment. The coil-type stmt can be maintained in this torqued compression condition by securing the ends of the coil-type stmt in position on a catheter
3 shaft. The ends are released by, for example, pulling on wires once at the target site. See, for example, U.S. Patent Nos. 5,372,600 and 5,476,505. Alternatively, the endoluminal prosthesis can be maintained in its reduced-diameter condition by a sleeve;
the sleeve can be selectively retracted to release the prosthesis. A third approach is the most common.
A balloon is used to expand the prosthesis at the target site. The stmt is typically extended past its elastic limit so that it remains in its expanded state after the balloon is deflated and removed. One balloon expandable stmt is the Palmaz-Schatz stmt available from the Cordis Division of Johnson & Johnson. Stems are also available from Medtronic AVE of Santa Rosa, California and Guidant Corporation of Indianapolis, Indiana.
SUMMARY OF THE INVENTION
The present invention is directed to an endoluminal prosthesis and a method for treating a dissection, as well as other tissue separation conditions, within blood vessels and other tubular body structures, using an endoluminal prosthesis.
A first aspect of the invention is directed to an endoluminal prosthesis which includes a coiled body and a graft material covering at least part of the coiled body to create a coiled stmt graft. The average stmt graft diameter to turns-width ratio may be about 0.8 to 1 to about 2.4 to 1 when expanded. The average turns-width to stmt graft length ratio, when expanded, may be about 1 to 1 to about 1 to 4. Adjacent turns of the stmt graft may lie adjacent to, or may be spaced apart from, one another when in the radially expanded condition.
This invention provides an endoluminal prosthesis comprising: a coiled body; a graft material covering at least a part of the coiled body to create a coiled stmt graft movable between radially expanded and radially contracted conditions;
said coiled stmt graft having turns with edges and a width measured perpendicular to said edges, said stmt graft placeable in the radially contracted condition for placement and in the radially expanded condition for use; wherein when in the radially expanded condition, said stmt graft has an average stmt graft diameter to turns-width ratio from about 0.8 to 1 to about 2.4 to 1.
This invention also provides an endoluminal prosthesis comprising: a coiled body; a graft material covering the coiled body to create a coiled stmt graft
4 movable between radially expanded and radially contracted conditions; said coiled stmt graft having turns with edges and a width measured perpendicular to said edges, said stmt graft placeable in the radially contracted condition for placement and in the radially expanded condition for use; adjacent turns of the coiled stmt graft lying adjacent to one another when in the radially expanded condition; said rail elements being parallel to one another and said connector elements being arranged at acute angles to the rail elements so that when in the radially contracted condition, said rail elements extend generally parallel to an axis created by the stmt graft; and wherein when in the radially expanded condition, said stmt graft has an average stmt graft diameter to turns-width ratio from about 0.8 to 1 to about 2.4 to 1.
This invention also provides an endoluminal prosthesis assembly comprising: a placement catheter comprising a shaft; an endoluminal prosthesis, releasably mountable to the shaft, comprising: a coiled body; a graft material covering at least a part of the coiled body to create a coiled stmt graft movable between radially expanded and radially contracted conditions; said coiled stmt graft having turns with edges and a width measured perpendicular to said edges, said stmt graft placeable in the radially contracted condition for placement and in the radially expanded condition for use; wherein when in the radially expanded condition, said stmt graft has an average stmt graft diameter to turns width ratio from about 0.8 to 1 to about 2.4 to 1; and the placement catheter comprising a release element having a distal portion engaging at least one of the distal and proximal ends of the stmt graft at first and second axially spaced-apart positions at said at least one end so to help maintain said at least one end against the shaft when in the radially contracted condition.
This invention also provides an endoluminal prosthesis comprising: a coiled body; a graft material covering at least a part of the coiled body to create a coiled stmt graft movable between radially expanded and radially contracted conditions; said coiled stmt graft having turns with edges and a width measured perpendicular to said edges, said stmt graft placeable in the radially contracted condition for placement and in the radially expanded condition for use; wherein when in the radially expanded condition, said stmt graft has an average turns-width to stmt graft length ratio from about 1 to 1 to about 1 to 4.

This invention also provides the use of an endoluminal prosthesis of this invention for treating a tissue separation condition within a tubular body structure or for treating a dissection within the aortic arch of a patient.
Another aspect of the invention is directed to a method for treating a tissue separation, such as a vascular dissection, within a tubular body structure.
The tissue separation condition comprises separated tissue defining a gap between the separated tissue and the remainder of the tubular body structure. The method includes placing an endoluminal prosthesis in a radially contracted condition at a target site, the endoluminal prosthesis comprising a coiled body with a graft material covering at least part of the coiled body to create a coiled stmt graft. The stmt graft is expanded to a radially expanded condition thereby pressing the separated tissue against the remainder of the tubular body structure.
This invention also provides a method for treating a tissue separation condition within a tubular body structure, the tissue separation condition comprising separated tissue defining a gap between the separated tissue and the remainder of the tubular body structure, comprising: placing an endoluminal prosthesis in a radially contracted condition at a tissue separation condition target site, the endoluminal prosthesis comprising: a coiled body; and a graft material covering at least a part of the coiled body to create a coiled stmt graft movable between radially expanded and radially contracted conditions, adjacent turns of the coiled stmt graft lying adjacent to one another when in the radially expanded condition, said turns having edges and a width measured perpendicular to said edges, said stmt graft placeable in the radially contracted condition for placement and in the radially expanded condition for use; and expanding the stmt graft towards the radially expanded condition thereby pressing against the separated tissue to help press the separated tissue against the remainder of the tubular body structure.
This invention also provides a method for treating a dissection within the aortic arch of a patient comprising: obtaining an endoluminal prosthesis;
placing the endoluminal prosthesis within an aortic arch in a radially contracted condition at a target site, the target site being an entry opening into a false lumen, the dissection comprising separated tissue defining the false lumen between the separated tissue and the remainder of the aortic arch, the endoluminal prosthesis comprising: a coiled body; and a graft material covering at least a part of the coiled body to create a coiled stmt graft movable between radially expanded and radially contracted conditions, adjacent turns of the coiled stmt graft lying adjacent to one another when in the radially expanded condition, said turns having edges and a width measured perpendicular to said edges, said stmt graft placeable in the radially contracted condition for placement and in the radially expanded condition for use; and the obtaining step being carried out so that when in the radially expanded condition, said stmt graft has an average stmt graft diameter to turns width ratio from about 0.8 to 1 to about 2.4 to 1; and expanding the stmt graft towards the radially expanded condition thereby pressing against the separated tissue to help press the separated tissue against the remainder of the tubular body structure.
This invention also provides the use of an endoluminal prosthesis for treating a tissue separation condition within a tubular body structure, the tissue separation condition comprising separated tissue defining a gap between the separated tissue and the remainder of the tubular body structure, wherein, the endoluminal prosthesis comprises:
a coiled body; and a graft material covering at least a part of the coiled body to create a coiled stmt graft movable between radially expanded and radially contracted conditions, adjacent turns of the coiled stmt graft lying adjacent to one another when in the radially expanded condition, said turns having edges and a width measured perpendicular to said edges, said stmt graft being for placement in the radially contracted condition.
This invention also provides a kit comprising an endoluminal prosthesis and instructions for use of the prosthesis according to a use or method of this invention as described above, wherein the prosthesis comprises: a coiled body; and a graft material covering at least a part of the coiled body to create a coiled stmt graft movable between radially expanded and radially contracted conditions, adjacent turns of the coiled stmt graft lying adjacent to one another when in the radially expanded condition, said turns having edges and a width measured perpendicular to said edges, said stmt graft being for placement in the radially contracted condition.
Other features and advantages of the invention will appear from the following description in which the preferred embodiments have been set forth in detail in conjunction with the accompanying drawings.

BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 illustrates a stmt blank used to create a coiled stmt such as those shown in Figs. 3, 4 and SA;
Figs. lA-1D illustrate four additional designs of stmt blanks;
Fig. lE shows a coiled stmt made from the stmt blank of Fig. 1B;
Fig. 2 illustrates a stmt blank similar to that of Fig. 1 but having different thickness along its length;
Fig. 3 illustrates a stmt graft in a radially expanded condition, the stmt graft including a stmt similar to that shown in Fig. 1 covered with a sleeve of porous graft material, the stmt graft having a central turn with a greatly increased pitch for placement at a branching intersection;
Fig. 4 illustrates a stmt graft similar to that of Fig. 3 but in which one end of the stmt graft has much greater radially expanded diameter than the other portion to accommodate a vessel having different internal diameters;
Fig. 5 illustrates an alternative embodiment to the stmt graft of Fig. 3 in which the stmt graft has a large expanded diameter and also has the one turn with the greater pitch at one end of the stmt graft;
Fig. SA shows a stmt graft similar to that of Fig. 3 but with generally evenly-spaced turns;
Fig. SB and SC illustrate stmt grafts made from the stmt blank of Fig. 1C;
Fig. 6A is an overall view of the distal end of a three-shaft deployment catheter used to deploy the stmt grafts of Figs. 3-5;
Fig. 6B is an end view of the shafts of 6A;
Fig. 6C is an embodiment similar to the catheter of Fig. 6A but including only inner and outer shafts;
Fig. 6D illustrates a proximal end adapter mounted to the proximal end of the catheter of Fig. 6C;
Fig. 6E illustrates an alternative embodiment of the catheter of Fig. 6C;
Figs. 6F and 6G are simplified side and cross-sectional views of a further alternative embodiment of the catheter of Figs. 6A and 6B;

Fig. 7A illustrates the stmt graft of Fig. 3 tightly wrapped about the distal end of the catheter of Figs. 6A and 6B and placed within a vessel with the intermediate portion of the stmt graft at the intersection of the main and branching vessels;
Fig. 7B illustrates the release of the proximal half of the stmt graft;
Fig. 7C illustrates the release of the distal half of the stmt graft prior to the removal of the catheter shafts;
Fig. 7D illustrates the stmt graft of Fig. SC tightly wrapped about a placement catheter;
Fig. 7E illustrates the stmt graft of Fig. 7D with the distal end of the stmt graft released from the catheter and the proximal end of the stmt graft releasably secured to the catheter at two positions;
Figs. 8 and 9 illustrate the placement of radiopaque marks at different positions along a coiled ladder-type stmt having a central turn with a greatly increased pitch;
Fig. 10 illustrates one example of a radiopaque marker shaped to permit the determination of the orientation of the prosthesis as well as its location; and Fig. 11 illustrates of the stmt graft of Fig. SB within the true lumen of the aortic arch at the entry of an aortic dissection, an alternative aortic dissection being shown in dashed lines.
DESCRIPTION OF THE SPECIFIC EMBODIMENTS
Fig. 1 illustrates a stmt blank 104 used to create a coiled stmt similar to that shown in Figs. 3, 4 and SA. Stent blank 104 includes a main body portion 106 and first and second end portions 108. Main body portion 106 includes side edge or rail elements 110 connected by connector or rung elements 112. Rung elements 112 are, as shown in Fig. 1, at an angle to rail elements 110 so that when stmt blank 104 is formed into a coiled stmt and tightly wrapped about an introducer catheter, such as in Fig. 17A, rung elements 112 are axially-extending so that they lie flat for a tighter wrap.
End portions 108 are thinner and thus more flexible than main body portion 106. In addition, end portions 108 have an inwardly tapering portion terminating at a blunt tip 115. The shape of end portions 108 and the lessened stiffness of the end portions, compared to body portion 106, help to prevent tissue trauma during use.

This type of coiled stmt in which the end portions 108 are less stiff than the main body portion 106 can find particular utility in stabilizing a traumatic injury site within a patient, such as in the case of a dissection, flap or false lumen. End portion 108 could also be more stiff than main body portion; this embodiment may be useful, for example, when treating occlusive disease on either side of a branch vessel.
Fig. 2 illustrates a stmt blank 104A similar to stmt blank 104 of Fig. 1 but in which main body portion 106A has three different radial stiffnesses. That is, main body portion 106A has a first, central longitudinal section 116 of a first, greater stiffness, and second and third longitudinal sections 118, 120 on either side of first section 116.
Sections 118, 120 are successively thinner and thus have successively lower radial stiffnesses when stmt blank 104A is formed into a coiled stmt. End portion 108A acts as the fourth longitudinal section with the least radial stiffness of any of the sections in this embodiment. Instead of a set of generally discrete radial stiffnesses, the radial stiffness could vary continuously along at least part of the length of stmt blank 104A, and then along the resulting stmt body.
In addition to providing less traumatic end portions 108, 108A, a coiled prosthesis formed from either of stmt blanks 104, 104A, when uncoiling, will have a tendency to open up first in the center, because of the greater stiffness at the center, followed by the ends. This helps to reduce the degree to which the end portions 108, 108A are dragged along the surface of the vessel or other hollow body structure as the prosthesis is released.
Figs. lA-1D illustrate four different designs of stmt blanks 104B-104E.
Each of these different stmt blanks has at least three rail elements 110 with connector or rung elements 112 extending between the rail elements. In the Figs. lA-1C
embodiments connector elements 112 are aligned while in the 1D embodiment they are offset.
The angles of connector elements 112 are such that when the stmt blanks are formed into a tight coil during introduction, connector elements 112 are generally axially extending so they lie flat for a tighter wrap. Fig. lE illustrates a coiled stmt lOSC made from stmt blank 104C with one or more radiopaque markers 121 used to facilitate deployment.
Stent blanks 104B-104E are relatively wide so to increase the radial force the coiled stems can apply to the walls of the hollow body organ within which they are to be placed.
It has been found that reducing the number of turns for a stmt graft having the same axial length helps to increase the user's control of the stmt graft during placement. This is important in certain situations, such as when treating a dissection, in particular a vascular dissection such as the aortic dissection shown in Fig. 11 and discussed below.
Also, as discussed above, the ends of stmt blanks 104B-104E may be rounded or thinned in shape
5 to cause a reduction in the radial force applied at the ends of the stmt to help prevent vessel deformation at the ends of the stmt.
Figs. 3, 4, 5 and 5A illustrate four stmt graft embodiments 122, 122A, 122B, 122C. Stent graft 122 includes a ladder-type coiled stmt formed from stmt blank 104 and covered with tubular graft material 124. Graft material 124 is preferably porous 10 PTFE or ePTFE or Dacrori polyester. The ends 126 of graft material 124 are sealed, or for example, by using an adhesive or by placing a suitable heat seal material, such as FEP
(fluorinated ethylene propylene) or other thermoplastic materials, between the layers of the graft material 124 and applying heat and pressure. The porous nature of the graft material permits sealing in this manner in spite of the inert nature of PTFE.
In addition, a direct bond of the PTFE to itself, via a process known as sintering, may be employed.
Other methods for sealing ends 126 could also be used. Coiled stmt graft 122 includes a number of spaced apart turns 128 defining a generally helical gap 130 therebetween.
The average width of helical gap 130 is equal to about 0% to 1200% of the average width of turns 128. For some applications the average width of gap of 130 is about 50% to 800% of the average width of turns 128 when stmt graft 122 is deployed.
For other applications, such as placement at dissections discussed below, gap 130 is closed, that is about 0%.
Stent graft 122 has a generally constant pitch except at its central region.
The pitch of a central turn 132 of stmt graft 122 is substantially greater than the pitch of its adjacent turns 128 to accommodate placement of stmt graft 122 at the intersection of a main or first vessel and a branching vessel as will be discussed in more detail with reference to Figs. 7A-7C.
Fig. 4 illustrates a stmt graft 122A in which a central turn 132A also has an increased pitch as opposed to adjacent turns 128A. However, the turns on one side of central turn 132A have a larger fully-expanded diameter than turns on the other side to accommodate transition between smaller and larger diameter vessels.

Fig. 5 illustrates a stmt graft 1228 designed for placement with the end turn 134 having a substantially greater pitch than its adjacent turn 128B.
Stent graft 1228 is used when one end of the stmt graft is to be positioned at the intersection and main and branching vessels so that the stmt graft extends to one side of the intersection as opposed to both sides as in the embodiments of Figs. 3 and 4. Fig. SA illustrates stmt graft 122C, which may be used at locations other than bifurcations, having generally uniformly spaced turns 128C.
Figs. SB and SC illustrate stmt grafts 122C, 112D each made from stmt blank 104D of Fig. 1 C. Stent grafts 122C, 122D are designed and intended to have the edges 135 of adjacent turns 137 adjacent to one another. Such stmt grafts as Figs. SB and SC are intended for use in treating aortic dissections. The combination of having the width of each turn being relatively wide compared to the diameter when in the radial expanded condition, plus the use of abutting or overlapping adjacent edges, combine to make such a stmt graft useful when full surface coverage and reasonably higher outward radial force are desired. The width of turns 137 is measured perpendicular to edges 135.
Also, fewer turns can make the stmt graft easier to control and require fewer rotations of shafts 138, 142 prior to release from catheter 136. Stent grafts 122C, 122D
may be characterized by having an average diameter to turns-width ratio, when in their radially expanded conditions, from about 0.1 to 1 to about 2.4 to 1. Stent grafts 122C, 122D may also be characterized by having an average turns-width to stmt graft length ratio, when in their radially expanded conditions, from about 1 to 1 to about 1 to 4. In some situations it may not be necessary or desired to have connectors 112 be axially extending when in the tightly wound, radially contracted condition. In some cases connectors 112 could be replaced by other shapes of connectors, such as wave- or undulating-shaped connectors, v-shaped connectors, x-shaped connectors, etc.
Figs. 6A-6B illustrate a catheter 136 used for deploying the stmt grafts of Figs. 3 and 4. Catheter 136 includes outer, intermediate and inner rotating, telescoping shafts 138, 140, 142 each having a distal end 144, 146, 148. Each of the shafts has a prosthesis portion holder 150, 1 SOA, 1508 at its distal end 144, 146, 148.
Prosthesis portion holders 150, 150A, 1508 include pull wires 152, 152A, 1528 which pass along axially-extending lumens 154, 154A, 1548 formed in the body of shafts 138, 140, 142, out of exit holes 156, 156A, 1568, across gaps 158, 158A, 1588 and back into reinsertion openings 160, 160A, 160B. Pull wires 152, 152A, 152B pass through and engage different portions of, for example, stmt graft 122 and secure those portions of the stmt graft to shafts 138, 140, 142. As shown in Fig. 7A, prosthesis portion holder 150B at distal end 148 of inner shaft 142 engages the distal end 166 of stmt graft 122. Holders 150, 150A at distal ends 144, 144A of outer and intermediate shafts 138, 140 engage proximal end 168 and central turn 132 of stem graft 122, respectively. One or more of shafts 138, 140, 142 may be braided to enhance torquing stiffness to aid rotation.
Fig. 6C illustrates the distal end of a catheter 136A including only two shafts, outer shaft 138A and inner shaft 142A. Catheter 136A is typically used when placing an endoluminal prosthesis of the type which does not have a central turn with an increased pitch, such as those of Figs. 5, 5A, 5B and 5C, and thus does not need a catheter with an intermediate shaft.
Figs. 6D illustrates, in a simplified form, a proximal end adapter 170 mounted to the proximal end of catheter 136A of Fig. 6C. Proximal end adapter includes distal and proximal portions 172, 176 through which catheter 136A
passes.
Proximal end adapter 170 provides for the rotation of either or both shafts 138A, 142A
through the manipulation of thumb wheel 174 mounted to portion 176. A flip lever 175 extends from distal portion 172 and is movable between secured and released positions to either secure shafts 138A, 142A to one another or to permit shafts 138A, 142A
to move axially relative to one another. Pull wires 152, 152B are normally secured to their respective shafts 138A, 142A by deployment knobs 178, 180; pulling on deployment knobs 178, 180 releases pull wires 152, 152B, respectively to permit the pull wires to be pulled to release the endoluminal prosthesis from the appropriate holder 150, 150B.
Figs. 6F and 6G illustrate a further three-shaft embodiment of the invention similar to the three -shaft embodiment of Figs. 6A and 6B. Instead of using lumens 154 to house pull wires 152, tubular members 162, 162A, 162B, typically hypotubes, could be secured to the outside of the shafts 138B, 140B, 142B.
Gaps or breaks are provided at the distal ends of hypotubes 162, 162A, 162B to define the gaps 158, 158A, 158B.
Fig. 7A shows stmt graft 122 of Fig. 3 tightly wrapped about catheter 136.
Distal end 166, proximal end 168 and central turn 132 of stmt graft 122 are secured to distal ends 148, 144 and 146 of inner, outer and intermediate shafts 142, 138 140 by prosthesis portions holders 150. Stent graft 122 is housed within a main vessel 182 with central turn 132 aligned with the intersection 184 of main vessel 182 and branching vessel 186. To help ensure proper placement of central turn 132 at intersection 184, stmt graft 122 has one or more remote visualization markers at or adjacent to turn 132.
Radiopaque markers 188, 190 192 are shown in Fig. 8 at distal, intermediate and proximal portions of the central turn 194 of stmt 196. Radiopaque markers may be shaped to provide information as to both location and orientation of stmt 196 on the catheter.
For example, radiopaque marker 190A of Fig. 9 has a broad central portion 1908 extending between rail elements 110 and arm portions 190C extending along rail elements 110;
this permits marker 190A to provide both location and orientation information about stmt 196A.
Orientation marker 190A is configured so that the viewer can determine whether the turn is facing the viewer or is away from the viewer based upon the marker's orientation.
Various other marker shapes to provide both location and orientation can also be used.
Radiopaque markers may also be used on the placement catheter itself.
For example, radiopaque markers 191, 193, 195 are used on shafts 1388, 1408, aligned with their respective holders 150, 150A, 1508, as shown in Fig. 6F, to indicate the location of the holders. Radiopaque marker 193 is shown to be configured as an orientation specific marker to help in the proper placement of the prosthesis.
Fig. 10 illustrates the shape of an orientation-specific radiopaque marker 197 which could be placed, for example, on shafts 138, 140, 142 at one or more of the holders 150 of the embodiments of Figs. 6A, 6C and 6E. Radiopaque or other remote visualization markers may also be used at other positions along the endoluminal prosthesis, such as at each end, or along the placement catheter.
Fig. 7B illustrates the release of proximal end 168 of stmt graft 122 while Fig. 7C illustrates the subsequent release of distal end 166 of stmt graft 122. It should be noted that central turn 132 remains secured to intermediate shaft 140 while the distal and proximal ends 166, 168 of stmt graft 122 are released to ensure that the open region of central turn 122 remains facing intersection 184 to help ensure substantially unrestricted fluid flow between main vessel 182 and branching vessel 186. It should also be noted that prior to releasing the stmt graft, the number of turns can be increased or decreased by the relative rotation of shafts 138, 140 and 142. Also, the length of stmt graft 122 can be changed by the relative axial sliding motion among outer, intermediate and inner shafts 138, 140, 142. For example, instead of simply releasing proximal end 168 of stmt graft 122 to the position shown in Fig. 7B, it may be desired to rotate outer shaft relative to intermediate shaft 140, keeping intermediate and inner shafts 140, 142 stationary so to unwind the proximal half of the stmt graft to ensure that the stmt graft is properly positioned prior to releasing the stmt graft. Similarly, both outer shaft and inner shafts can be rotated while maintaining intermediate shaft stationary to create the expanded diameter condition of Fig. 7 prior to releasing any portion of the stmt graft.
In this way the physician can ensure that stmt graft 122 is properly positioned, especially with respect to central turn 132. If necessary or desired, intermediate shaft 140 could be, for example, rotated relative to outer and inner shafts 138, 142 to help properly position or reposition central turn 132.
Fig. 7A also shows how by properly selecting the angle of connector elements 112 relative to side elements 110 for a placement catheter of a particular outside diameter, connector elements 112, indicated by dashed lines in Fig. 7A, will lie generally parallel to the axis of stmt graft 122. This permits connector element 112 to lie closer to catheter 136, to provide a much smoother wrap when in its contracted, reduced-diameter state, than would result if connector elements were not generally parallel to the axis in such a state. This axial orientation can be contrasted with the off axis orientation of connectors 112 when in the expanded diameter state of Fig. 7C. The smoother outer surface of stmt graft 122 enhances the ease of insertion of the stmt graft within a hollow body organ, such as blood vessel 182.
Fig. 7D illustrates stmt graft 122D of Fig. SC tightly wrapped about placement catheter, 136A of Fig. 6C with the proximal end of stmt graft 122D
secured to outer catheter shaft 138A and the distal end of stmt graft 122D secured to inner catheter shaft 142A. Fig. 7E illustrates the structure of Fig. 7D after pull wire 152B
has been pulled to release the distal end of stmt graft 122D. Soon thereafter pull wire 152 will be pulled to release the proximal end of stmt graft 122D from outer catheter shaft 138A.
Because of the width of each turn of stmt graft 122D, each pull wire 152, 152B
passes through two positions 199 along an end of stmt graft 122D to ensure that the stmt graft lies tightly against catheter 136A during delivery.
As discussed above, stmt graft 122D is placed in a radially contracted condition by rotating inner and outer catheter shafts 138A ,142A relative to one another.

Once in position for deployment, catheter shafts 138A, 142A are rotated relative to each other to open stmt graft 122D. Shafts 138A, 142A can also be moved longitudinally (axially) relative to one another to allow one to change the pitch and ensure that edges 135 of turns 137 of stmt graft 122 will be adjacent to one another when fully deployed, as 5 is often desired. At any point the operator can decide to retighten stmt graft 122D, placing it in a radially contracted condition, to reposition the stmt graft or change the pitch so long as pull wires 152, 1528 have not been removed from the ends of the stmt graft. Proper placement of the graft 122D, including ensuring that the edges lie adjacent to one another, can be aided by the used of radiopaque markers 121. See Fig.
lE.
10 Fig. 11 illustrates the placement of stmt graft 122C within the true lumen 200 of an aortic arch 202 so to cover the entry 204 into a false lumen 206 created by an aortic dissection 208. Aortic dissections are of various type but all include a false lumen caused by separation of the lining, such as intimal lining 210, from the remainder of the wall, such as wall 212 of the hollow body structure, together with an entry formed 15 through the separated lining into the false lumen. Aortic dissections, as well as other dissections, may be of the type with a single entry 204 or may include, for example, an entry and an exit. An alternative dissection 208A is suggested by the dashed lines in Fig.
11 indicating an extension of aortic dissection 208 from the solid line portion down to an exit 214 adjacent bifurcation 216. While it may be possible to close both entry 204 and exit 214 using one or more stmt grafts, it may not be necessary or desirable.
Also, it may not be necessary to cover either the entrance andlor any exit to a false lumen with the stmt graft to effectively treat the dissection. Stent graft 122C also has dashed lines indicating the locations of rail elements 110 and connector elements 112 of the stmt.
Stent graft 122C is used with a thoracic level aortic dissection. Stent grafts may be used with dissections at other levels along aorta 218, such as at the abdominal level 220 or along the arch 222. When a stmt graft is used at arch 222, or at other hollow body regions with one or more branches, stmt grafts having one or more enlarged gaps, see Figs. 3, 4 and 7C, may be used to help prevent obstruction of the branching vessel.
Stent grafts, such as those of Figs. 5B and SC, may be used to help repair various dissections other than aortic dissections. In particular, such stmt grafts may be used for other types of vascular dissections and dissections in other hollow body organs within which dissections may be found. The dissections may be created as a result of non-penetrating trauma or invasive trauma as well as biological reasons, such as disease, stress, congenital disorders, etc.
Modification and variation can be made to the above described invention without departing from the subject of the invention as defined in the following claims.
For example, connectors 112 could be oriented perpendicular to rail elements 110, graft material 124 could be placed upon only a portion of the underlying stmt or on only one side of the underlying stmt. Placement catheter 136 could include fewer or additional telescoping rotatable shafts. The telescoping shafts may not need to be coaxial shafts slidable within or over one another; the telescoping shafts could be, for example, solid and/or tubular elongate members positioned side-by-side. Holders 150 could be constructed differently; for example, if the sequence of releasing the prosthesis is known it may be possible to use a single pull wire instead of three separate pull wires.

Claims (39)

WHAT IS CLAIMED IS:
1. An endoluminal prosthesis comprising:
a coiled body;
a graft material covering at least a part of the coiled body to create a coiled stent graft movable between radially expanded and radially contracted conditions;
said coiled stent graft having turns with edges and a width measured perpendicular to said edges, said stent graft placeable in the radially contracted condition for placement and in the radially expanded condition for use;
wherein when in the radially expanded condition, said stent graft has an average stent graft diameter to turns-width ratio from about 0.8 to 1 to about 2.4 to 1.
2. The endoluminal prosthesis according to claim 1 wherein adjacent turns of the coiled stent graft lie adjacent to one another when in the radially expanded condition.
3. The assembly according to claim 1 or 2, wherein the coiled stent graft comprises a gap between adjacent turns thereof so to aid placement at the intersection of a branching vessel with a main vessel.
4. The endoluminal prosthesis according to claim 1, 2 or 3, wherein the coiled stent graft has at least two full turns when in the radially expanded condition.
5. The endoluminal prosthesis according to claim 1, 2 or 3, wherein the coiled stent graft has at most two full turns when in the radially expanded condition.
6. The endoluminal prosthesis according to any one of claims 1-5, wherein the graft material fully covers the coiled body.
7. The endoluminal prosthesis according to any one of claims 1-6, wherein the coiled body comprises laterally spaced-apart, longitudinally extending rail elements and transversely extending connector elements connecting the rail elements.
8. The endoluminal prosthesis according to claim 7 comprising at least two of said rail elements.
9. The endoluminal prosthesis according to claim 7 comprising at least the three of said rail elements.
10. The endoluminal prosthesis according to claim 9 wherein said rail elements are parallel to one another and said connector elements are arranged at acute angles to the rail elements so that when in the radially contracted condition, said rail elements extend generally parallel to an axis created by the stent graft.
11. The endoluminal prosthesis according to any one of claims 1-10, wherein said stent graft comprises a radiopaque marker.
12. An endoluminal prosthesis comprising:
a coiled body;
a graft material covering the coiled body to create a coiled stent graft movable between radially expanded and radially contracted conditions;
said coiled stent graft having turns with edges and a width measured perpendicular to said edges, said stent graft placeable in the radially contracted condition for placement and in the radially expanded condition for use;
adjacent turns of the coiled stent graft lying adjacent to one another when in the radially expanded condition;
said rail elements being parallel to one another and said connector elements being arranged at acute angles to the rail elements so that when in the radially contracted condition, said rail elements extend generally parallel to an axis created by the stent graft; and wherein when in the radially expanded condition, said stent graft has an average stent graft diameter to turns-width ratio from about 0.8 to 1 to about 2.4 to 1.
13. An endoluminal prosthesis assembly comprising:
a placement catheter comprising a shaft;
an endoluminal prosthesis, releasably mountable to the shaft, comprising:
a coiled body;

a graft material covering at least a part of the coiled body to create a coiled stent graft movable between radially expanded and radially contracted conditions;
said coiled stent graft having turns with edges and a width measured perpendicular to said edges, said stent graft placeable in the radially contracted condition for placement and in the radially expanded condition for use;
wherein when in the radially expanded condition, said stent graft has an average stent graft diameter to turns width ratio from about 0.8 to 1 to about 2.4 to 1; and the placement catheter comprising a release element having a distal portion engaging at least one of the distal and proximal ends of the stent graft at first and second axially spaced-apart positions at said at least one end so to help maintain said at least one end against the shaft when in the radially contracted condition.
14. An endoluminal prosthesis comprising:
a coiled body;
a graft material covering at least a part of the coiled body to create a coiled stent graft movable between radially expanded and radially contracted conditions;
said coiled stent graft having turns with edges and a width measured perpendicular to said edges, said stent graft placeable in the radially contracted condition for placement and in the radially expanded condition for use;
wherein when in the radially expanded condition, said stent graft has an average turns-width to stent graft length ratio from about 1 to 1 to about 1 to 4.
15. The use of an endoluminal prosthesis or an endoluminal prosthesis assembly according to any one of claims 1-14 for treating a tissue separation condition within a tubular body structure or for treating a dissection within the aortic arch of a patient.
16. A method for treating a tissue separation condition within a tubular body structure, the tissue separation condition comprising separated tissue defining a gap between the separated tissue and the remainder of the tubular body structure, comprising:

placing an endoluminal prosthesis in a radially contracted condition at a tissue separation condition target site, the endoluminal prosthesis comprising:
a coiled body; and a graft material covering at least a part of the coiled body to create a coiled stent graft movable between radially expanded and radially contracted conditions, adjacent turns of the coiled stent graft lying adjacent to one another when in the radially expanded condition, said turns having edges and a width measured perpendicular to said edges, said stent graft placeable in the radially contracted condition for placement and in the radially expanded condition for use; and expanding the stent graft towards the radially expanded condition thereby pressing against the separated tissue to help press the separated tissue against the remainder of the tubular body structure.
17. A method according to claim 16 further comprising obtaining an endoluminal prosthesis so that when in the radially expanded condition, said stent graft has an average stent graft diameter to turns-width ratio from about 0.8 to 1 to about 2.4 to 1.
18. A method according to claim 16 further comprising obtaining an endoluminal prosthesis so that when in the radially expanded condition, said stent graft has an average turns-width to stent graft length ratio from about 1 to 1 to about 1 to 4.
19. A method according to claim 16, 17 or 18, wherein the placing step takes place within a vascular structure.
20. A method according to claim 19 wherein the placing step takes place within the aortic arch.
21. A method according to claim 16, 17 or 18, wherein the placing step takes place with the target site being an entry opening into a false lumen defined between the separated tissue of a dissection and the remainder of the tubular body structure.
22. A method according to claim 16, 17 or 18, wherein the placing step takes place at a dissection site, comprising an entry into and an exit out of a false lumen defined between the separated tissue and the remainder of the tubular body structure, with the target site being the entry.
23. A method according to claim 16, 17 or 18, wherein the placing step is carried out using a coiled stent graft having a gap between adjacent turns thereof.
24. A method according to claim 23 further comprising positioning the stent graft at a branching vessel target site with said gap generally aligned with a branching vessel.
25. A method for treating a dissection within the aortic arch of a patient comprising:
obtaining an endoluminal prosthesis;
placing the endoluminal prosthesis within an aortic arch in a radially contracted condition at a target site, the target site being an entry opening into a false lumen, the dissection comprising separated tissue defining the false lumen between the separated tissue and the remainder of the aortic arch, the endoluminal prosthesis comprising:
a coiled body; and a graft material covering at least a part of the coiled body to create a coiled stent graft movable between radially expanded and radially contracted conditions, adjacent turns of the coiled stent graft lying adjacent to one another when in the radially expanded condition, said turns having edges and a width measured perpendicular to said edges, said stent graft placeable in the radially contracted condition for placement and in the radially expanded condition for use; and the obtaining step being carried out so that when in the radially expanded condition, said stent graft has an average stent graft diameter to turns width ratio from about 0.8 to 1 to about 2.4 to 1; and expanding the stent graft towards the radially expanded condition thereby pressing against the separated tissue to help press the separated tissue against the remainder of the tubular body structure.
26. The use of an endoluminal prosthesis for treating a tissue separation condition within a tubular body structure, the tissue separation condition comprising separated tissue defining a gap between the separated tissue and the remainder of the tubular body structure, wherein, the endoluminal prosthesis comprises:
a coiled body; and a graft material covering at least a part of the coiled body to create a coiled stent graft movable between radially expanded and radially contracted conditions, adjacent turns of the coiled stent graft lying adjacent to one another when in the radially expanded condition, said turns having edges and a width measured perpendicular to said edges, said stent graft being for placement in the radially contracted condition.
27. The use of claim 26 wherein the endoluminal prosthesis is for pressing separated tissue against a remainder of the tubular body structure when the coiled stent graft is expanded toward the radially expanded condition.
28. The use of claim 26 or 27 wherein the stent graft in the radially expanded condition has an average stent graft diameter to turns-width ratio from about 0.8 to 1 to about 2.4 to 1.
29. The use of claim 26 or 27 wherein the stent graft in the radially expanded condition has an average stent graft diameter to turns-width ratio from about 1 to 1 to about 1 to 4.
30. The use of any one of claims 26-29, wherein the endoluminal prosthesis is for placement within a vascular structure.
31. The use of claim 30 wherein the vascular structure is the aortic arch.
32. The use of any one of claims 26-31, wherein the endoluminal prosthesis is for placement at an entry opening into a false lumen defined between separated tissue of a dissection and the remainder of a tubular body structure.
33. The use of any one of claims 26-31, wherein the endoluminal prosthesis is for placement at a dissection site comprising an entry into and an exit out of a false lumen defined between separated tissue and the remainder of a tubular body structure.
34. The use of any one of claims 26-33, wherein the coiled stent graft has a gap between adjacent turns thereof.
35. The use of claim 34 wherein the stent graft is for positioning with said gap being generally aligned with a branching vessel.
36. A kit comprising an endoluminal prosthesis and instructions for use of the prosthesis according to any one of claims 26-35, wherein the prosthesis comprises:
a coiled body; and a graft material covering at least a part of the coiled body to create a coiled stent graft movable between radially expanded and radially contracted conditions, adjacent turns of the coiled stent graft lying adjacent to one another when in the radially expanded condition, said turns having edges and a width measured perpendicular to said edges, said stent graft being for placement in the radially contracted condition.
37. The kit of claim 36, wherein the stent graft in the radially expanded condition has an average stent graft diameter to turns-width ratio from about 0.8 to 1 to about 2.4 to 1.
38. The kit of claim 36, wherein the stent graft in the radially expanded condition has an average stent graft diameter to turns-width ratio from about 1 to 1 to about 1 to 4.
39. The use of claim 36, 37 or 38, wherein the coiled stent graft has a gap between adjacent turns thereof.
CA002351794A 2000-06-30 2001-06-28 Endoluminal prosthesis for treatment of tissue separation condition Abandoned CA2351794A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/608,281 US6572648B1 (en) 2000-06-30 2000-06-30 Endoluminal prosthesis and tissue separation condition treatment method
US09/608,281 2000-06-30

Publications (1)

Publication Number Publication Date
CA2351794A1 true CA2351794A1 (en) 2001-12-30

Family

ID=24435787

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002351794A Abandoned CA2351794A1 (en) 2000-06-30 2001-06-28 Endoluminal prosthesis for treatment of tissue separation condition

Country Status (3)

Country Link
US (2) US6572648B1 (en)
AU (1) AU753962B2 (en)
CA (1) CA2351794A1 (en)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6702846B2 (en) * 1996-04-09 2004-03-09 Endocare, Inc. Urological stent therapy system and method
US6273913B1 (en) * 1997-04-18 2001-08-14 Cordis Corporation Modified stent useful for delivery of drugs along stent strut
US8382821B2 (en) * 1998-12-03 2013-02-26 Medinol Ltd. Helical hybrid stent
US20040267349A1 (en) 2003-06-27 2004-12-30 Kobi Richter Amorphous metal alloy medical devices
WO2002071975A2 (en) * 2001-03-13 2002-09-19 Yoram Richter Method and apparatus for stenting
GB2382776A (en) * 2001-11-21 2003-06-11 Tayside Flow Technologies Ltd Helix shaped insert for flow modification in a duct or stent
US20030195609A1 (en) * 2002-04-10 2003-10-16 Scimed Life Systems, Inc. Hybrid stent
DE10233085B4 (en) 2002-07-19 2014-02-20 Dendron Gmbh Stent with guide wire
US8425549B2 (en) 2002-07-23 2013-04-23 Reverse Medical Corporation Systems and methods for removing obstructive matter from body lumens and treating vascular defects
US20050065437A1 (en) * 2003-09-24 2005-03-24 Scimed Life Systems, Inc. Medical device with markers for magnetic resonance visibility
US8333798B2 (en) * 2003-11-07 2012-12-18 Merlin Md Pte Ltd. Implantable medical devices with enhanced visibility, mechanical properties and biocompatability
US9078780B2 (en) * 2003-11-08 2015-07-14 Cook Medical Technologies Llc Balloon flareable branch vessel prosthesis and method
DE602005025324D1 (en) 2004-03-31 2011-01-27 Cook Inc STENT STORAGE DEVICE
US8048140B2 (en) 2004-03-31 2011-11-01 Cook Medical Technologies Llc Fenestrated intraluminal stent system
EP2422751A3 (en) 2004-05-05 2013-01-02 Direct Flow Medical, Inc. Unstented heart valve with formed in place support structure
US20060058869A1 (en) * 2004-09-14 2006-03-16 Vascular Architects, Inc., A Delaware Corporation Coiled ladder stent
US20060136034A1 (en) * 2004-12-20 2006-06-22 Vascular Architects, Inc. Delivery catheter and method
US20060136033A1 (en) * 2004-12-20 2006-06-22 Vascular Architects, Inc. Coiled stent delivery system and method
US20060136035A1 (en) * 2004-12-20 2006-06-22 Vascular Architects, Inc. A Delaware Corporation Coiled endoluminal prosthesis system and delivery catheter
US7806922B2 (en) * 2004-12-31 2010-10-05 Boston Scientific Scimed, Inc. Sintered ring supported vascular graft
US20060246210A1 (en) * 2005-04-29 2006-11-02 Vascular Architects Inc., A Delaware Corporation Method for making a covered drug-eluting stent
US8118859B2 (en) * 2006-05-26 2012-02-21 Codman & Shurtleff, Inc. Occlusion device combination of stent and mesh having offset parallelogram porosity
US7935144B2 (en) * 2006-10-19 2011-05-03 Direct Flow Medical, Inc. Profile reduction of valve implant
US8133213B2 (en) 2006-10-19 2012-03-13 Direct Flow Medical, Inc. Catheter guidance through a calcified aortic valve
US20080269774A1 (en) 2006-10-26 2008-10-30 Chestnut Medical Technologies, Inc. Intracorporeal Grasping Device
US8002815B2 (en) * 2007-03-09 2011-08-23 Novostent Corporation Delivery system and method for vascular prosthesis
US9017395B2 (en) * 2007-03-09 2015-04-28 Novostent Corporation Vascular prosthesis and methods of use
US20080221658A1 (en) * 2007-03-09 2008-09-11 Novostent Corporation Vascular prosthesis and methods of use
US8348994B2 (en) * 2007-03-09 2013-01-08 Novostent Corporation Vascular prosthesis with alternating helical sections
EP2190379B1 (en) 2007-08-23 2016-06-15 Direct Flow Medical, Inc. Translumenally implantable heart valve with formed in place support
US8088140B2 (en) 2008-05-19 2012-01-03 Mindframe, Inc. Blood flow restorative and embolus removal methods
US11337714B2 (en) 2007-10-17 2022-05-24 Covidien Lp Restoring blood flow and clot removal during acute ischemic stroke
US8002816B2 (en) * 2007-12-21 2011-08-23 Cleveland Clinic Foundation Prosthesis for implantation in aorta and method of using same
AU2009217354B2 (en) 2008-02-22 2013-10-10 Covidien Lp Methods and apparatus for flow restoration
US10772717B2 (en) 2009-05-01 2020-09-15 Endologix, Inc. Percutaneous method and device to treat dissections
US9579103B2 (en) 2009-05-01 2017-02-28 Endologix, Inc. Percutaneous method and device to treat dissections
KR20120085238A (en) * 2009-07-09 2012-07-31 머레이 배스큘라 피티와이 리미티드 A support device for a tubular structure
US20110218608A1 (en) * 2009-09-10 2011-09-08 Novostent Corporation Vascular Prosthesis Delivery System and Method
US9603708B2 (en) 2010-05-19 2017-03-28 Dfm, Llc Low crossing profile delivery catheter for cardiovascular prosthetic implant
US9039749B2 (en) 2010-10-01 2015-05-26 Covidien Lp Methods and apparatuses for flow restoration and implanting members in the human body
US9149277B2 (en) * 2010-10-18 2015-10-06 Artventive Medical Group, Inc. Expandable device delivery
WO2012058104A1 (en) * 2010-10-28 2012-05-03 Cook Medical Technologies Llc Torsion constrained stent delivery system
WO2012068298A1 (en) * 2010-11-17 2012-05-24 Endologix, Inc. Devices and methods to treat vascular dissections
US8911468B2 (en) * 2011-01-31 2014-12-16 Vatrix Medical, Inc. Devices, therapeutic compositions and corresponding percutaneous treatment methods for aortic dissection
US9827121B2 (en) * 2013-03-15 2017-11-28 Cook Medical Technologies Llc Quick release deployment handle for medical devices
US10149968B2 (en) 2013-06-14 2018-12-11 Artventive Medical Group, Inc. Catheter-assisted tumor treatment
US9636116B2 (en) 2013-06-14 2017-05-02 Artventive Medical Group, Inc. Implantable luminal devices
US10076399B2 (en) 2013-09-13 2018-09-18 Covidien Lp Endovascular device engagement
US10813644B2 (en) 2016-04-01 2020-10-27 Artventive Medical Group, Inc. Occlusive implant and delivery system
US20170290691A1 (en) * 2016-04-12 2017-10-12 Idev Technologies, Inc. Stent deployment system including multiple stent-engaging elements
EP3484421A1 (en) 2016-07-13 2019-05-22 Boston Scientific Scimed Inc. Apparatus and method for maintaining patency in a vessel adjacent to nearby surgery
CN110267627B (en) 2016-12-09 2023-07-11 真复灵公司 Systems, devices, and methods for accurately deploying implants in the prostatic urethra
US11890213B2 (en) 2019-11-19 2024-02-06 Zenflow, Inc. Systems, devices, and methods for the accurate deployment and imaging of an implant in the prostatic urethra

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT392733B (en) 1981-09-16 1991-05-27 Medinvent Sa DEVICE FOR TREATING BLOOD VESSELS OR THE LIKE.
SE450809B (en) 1985-04-10 1987-08-03 Medinvent Sa PLANT TOPIC PROVIDED FOR MANUFACTURING A SPIRAL SPRING SUITABLE FOR TRANSLUMINAL IMPLANTATION AND MANUFACTURED SPIRAL SPRINGS
JPS63238872A (en) 1987-03-25 1988-10-04 テルモ株式会社 Instrument for securing inner diameter of cavity of tubular organ and catheter equipped therewith
US4795458A (en) 1987-07-02 1989-01-03 Regan Barrie F Stent for use following balloon angioplasty
US4886062A (en) 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
US5133732A (en) * 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US4913141A (en) 1988-10-25 1990-04-03 Cordis Corporation Apparatus and method for placement of a stent within a subject vessel
FR2671482A1 (en) * 1991-01-16 1992-07-17 Seguin Jacques Vascular endoprosthesis
US5147370A (en) 1991-06-12 1992-09-15 Mcnamara Thomas O Nitinol stent for hollow body conduits
US5282823A (en) * 1992-03-19 1994-02-01 Medtronic, Inc. Intravascular radially expandable stent
JPH05300945A (en) * 1992-04-28 1993-11-16 Olympus Optical Co Ltd Vital vascular cavity expander
US5772668A (en) 1992-06-18 1998-06-30 American Biomed, Inc. Apparatus for placing an endoprosthesis
US5342387A (en) * 1992-06-18 1994-08-30 American Biomed, Inc. Artificial support for a blood vessel
GB2270264B (en) 1992-09-02 1996-09-25 Ellis Dev Ltd Palliative stent and insertion device
US6027516A (en) 1995-05-04 2000-02-22 The United States Of America As Represented By The Department Of Health And Human Services Highly elastic, adjustable helical coil stent
US5833699A (en) * 1996-04-10 1998-11-10 Chuter; Timothy A. M. Extending ribbon stent
CA2252894A1 (en) * 1996-04-29 1997-11-06 W. L. Gore & Associates, Inc. Device for restoring competence to venous valves
US6048360A (en) * 1997-03-18 2000-04-11 Endotex Interventional Systems, Inc. Methods of making and using coiled sheet graft for single and bifurcated lumens
US5824053A (en) 1997-03-18 1998-10-20 Endotex Interventional Systems, Inc. Helical mesh endoprosthesis and methods of use
US5824052A (en) * 1997-03-18 1998-10-20 Endotex Interventional Systems, Inc. Coiled sheet stent having helical articulation and methods of use
US5961548A (en) * 1997-11-18 1999-10-05 Shmulewitz; Ascher Bifurcated two-part graft and methods of implantation
DE29721310U1 (en) 1997-12-02 1998-02-12 Schmitz Rode Thomas Dipl Ing D Spiral endoprosthesis that can be manufactured using the cutting process for implantation in hollow organs of the human body
US6156062A (en) * 1997-12-03 2000-12-05 Ave Connaught Helically wrapped interlocking stent
CA2335842A1 (en) * 1998-06-26 2000-01-06 Quanam Medical Corporation Topoisomerase inhibitors for prevention of restenosis
US6019779A (en) 1998-10-09 2000-02-01 Intratherapeutics Inc. Multi-filar coil medical stent
US6090134A (en) 1999-02-16 2000-07-18 Polymerex Medical Corp. Surface fluorinated stent and methods thereof
US6364904B1 (en) * 1999-07-02 2002-04-02 Scimed Life Systems, Inc. Helically formed stent/graft assembly

Also Published As

Publication number Publication date
US6572648B1 (en) 2003-06-03
AU5415601A (en) 2002-01-03
AU753962B2 (en) 2002-10-31
US20030225444A1 (en) 2003-12-04
US6921414B2 (en) 2005-07-26

Similar Documents

Publication Publication Date Title
AU753962B2 (en) Endoluminal prosthesis and tissue separation condition treatment method
US6660032B2 (en) Expandable coil endoluminal prosthesis
US20020077693A1 (en) Covered, coiled drug delivery stent and method
EP1156758B1 (en) Coiled stent
US6562064B1 (en) Placement catheter assembly
US6974473B2 (en) Function-enhanced thrombolytic AV fistula and method
US6572643B1 (en) Endoprosthesis delivery catheter assembly and method
EP1061985B1 (en) Delivery system for deployment and endovascular assembly of multi-stage stent graft
US20060136034A1 (en) Delivery catheter and method
CA2263837C (en) An aggregate for transluminal insertion of a tubular stent, and an endovascular graft device
WO2002049544A9 (en) Biologically active agent delivery apparatus and method
US20020072790A1 (en) Methods of implanting covered stents with side branch
US20060058869A1 (en) Coiled ladder stent
US20060136035A1 (en) Coiled endoluminal prosthesis system and delivery catheter
EP3917461A2 (en) Expandable luminal stents and methods of use
CA2945185A1 (en) Push and pull medical device delivery system
US20060136033A1 (en) Coiled stent delivery system and method
AU2005319474A1 (en) Coiled endoluminal prosthesis system, delivery catheter and method

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued